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Medication administration errors are a problematic issue in Australia and worldwide, 
despite previous attempts to reduce medication errors. Most interventions to date focus 
on isolated, discrete elements and fail to involve nurses in developing solutions. 
Medications errors in children are of particular concern because they are more susceptible 
to harm than adults.  
 
This research aimed to recruit nurses to participate in an Action Research Team (ART) 
to develop, implement and evaluate interventions to reduce medication errors in 
paediatric patients.  
 
The action research methodology was used over three phases of the study. Phase One 
aimed to build an overall picture of medication practice in the participating ward. The 
results of practice observation, medication policy audits, the Safety Attitudes 
Questionnaire (SAQ), the incident data and focus groups showed that the medication error 
rate on the ward was higher than the average error rate across the hospital. The 
contributing factors for these results included busy-ness of the ward, lack of resources 
and small size of the physical environment, lack of feedback from management, 
impractical medication policy, and the nurse’s perception of medication errors.  
 
Phase Two aimed to develop and implement targeted interventions in the participating 
ward. The multi-disciplinary research team recruited six clinical nurses to be part of this 
phase (ART nurses). Five interventions were developed and implemented, moving the 
medication administration time two hours earlier in the evening shift, introducing 
medication trollies, updating the medication policy, implementing Safety and Quality 
meetings (S&Q) and modifying the patient admission forms. Data from the ART meeting 
minutes and semi-structured interviews with ART nurses were collected to explore the 
influence of the nurse’s participation in this research. The results indicated that ART 
nurses changed from being stressed and worried about understanding research, to 





The effectiveness of the interventions was evaluated in Phase Three with Phase One data 
repeated. Additionally, eight semi-structured interviews with the ward nurses were 
undertaken to explore their perception of the interventions and their experience during 
the research journey.  
 
Nurses were able to contribute to the research when they were provided with the 
opportunity and support, which enabled them to take ownership of the research and the 
subsequent changes they led. The results indicated a noteworthy reduction in the 
medication administration errors by 57.4% and an increased parent/carer engagement in 
medication administration at the bedside. 
